Patents Assigned to Meshaberase, LLC
  • Publication number: 20180042870
    Abstract: The present disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or derivatives thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.
    Type: Application
    Filed: September 8, 2017
    Publication date: February 15, 2018
    Applicant: Meshaberase, LLC
    Inventors: Benjamin RUBIN, Raj PURI, Bharat JOSHI